Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2022-04-01
Seri Bilgileri:Thrombosis Journal
Konular:
Ticagrelor
Platelet inhibition rate
Thromboelastography
Acute coronary syndrome
Online Erişim:https://doi.org/10.1186/s12959-022-00380-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller